Dr. Behnood Bikdeli and Dr. C. Michael Gibson Discuss: HI-PRO (Apixaban vs Placebo to Prevent Recurrences in Provoked Venous Thromboembolism With Enduring Risk Factors: One-Year Extension Results From the HI-PRO Trial) November 7, 2026 Disclosures: TBD
Dr. Todd Villines and Dr. C. Michael Gibson Discuss: PARAMOUNT (A Randomized Comparison of Personalized Management for Medical and Interventional Therapy Based on Coronary Atherosclerotic Plaque versus Usual Care for Symptomatic Patients With Suspicion of Coronary Artery Disease: Primary Results of the PARAMOUNT Trial) November 7, 2026 Sponsored by Cleerly
Dr. Steven Nissen and Dr. C. Michael Gibson Discuss: HORIZON (Effect of Pelacarsen on Cardiovascular Outcomes in Patients With Elevated Lipoprotein(a): Primary Results From the Lp(a) HORIZON Trial) November 7, 2026 Disclosures: TBD
Dr. Paul Ridker and Dr. C. Michael Gibson Discuss: ZEUS (Primary Report of the Ziltivekimab Cardiovascular Outcomes Trial) November 7, 2026 Disclosures: TBD
In a complex real world comparison of about 500,000 patients, the addition of Repatha lowered cardiovascular outcomes 20% more than ezetimibe. Dr. Nihar Desai and Dr. C. Michael Gibson discuss the results. November 5, 2026 Disclosures: TBD
Dr. Maximilian Autherith and Dr. C. Michael Gibson Discuss: Routine Post-Dilation vs. Conventional Deployment for Balloon-Expandable TAVR: The Randomized DUOTAP Trial November 4, 2026 Disclosures: TBD
Dr. Xianbao Liu and Dr. C. Michael Gibson Discuss: Single vs. Double ProGlide Devices for Access Site Closure After Transfemoral TAVR: The SINGLE-CLOSURE Trial November 3, 2026 Disclosures: TBD
Dr. Iñigo Lozano and Dr. C. Michael Gibson Discuss: Platelet Function Testing to Guide P2Y12 Inhibitor De-Escalation After ACS: The EPIC17-VERONICA Randomized Trial November 3, 2026 Disclosures: TBD
Dr. Patrick Serruys and Dr. C. Michael Gibson Discuss: Angiography-Derived FFR vs. Usual Care for Lesion Selection and Optimization in All-Comers PCI: Final Results of the PIONEER IV Randomized Trial November 3, 2026 Disclosures: TBD
Dr. Charles Davidson, Dr. Suzanne Arnold and Dr. C. Michael Gibson Discuss: Transcatheter Tricuspid Valve Repair with the PASCAL System vs. Medical Therapy for Severe, Symptomatic Tricuspid Regurgitation: Clinical and Health Status Outcomes from the CLASP II TR Randomized Trial November 2, 2026 Disclosures: TBD
